Letter to the Editor: mTOR-Inhibitor-Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia

被引：3
|
作者：
Castellote, Jose [1 ,2 ,3 ]
Mora Lujan, Jose Maria [1 ,4 ]
Riera-Mestre, Antoni [1 ,3 ,4 ]
机构：
[1] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, HHT Unit, Barcelona, Spain
[2] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Digest Dis, Hepatol & Liver Transplant Unit, Barcelona, Spain
[3] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain
[4] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Barcelona, Spain
来源：
HEPATOLOGY | 2020年 / 71卷 / 02期
关键词：
D O I：
10.1002/hep.30870
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：762 / 763
页数：3
相关论文
共 50 条
  • [41] Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman, Michael A.
    Trotter, James F.
    Wachs, Michael
    Bak, Tom
    Campsen, Jeffrey
    Kam, Igal
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 470 - 470
  • [42] Stratification of Kidney Transplant Recipients into Those with Low and High Alloreactive T-Cells May Allow Safe Conversion to mTOR-Inhibitor-Based Immunosuppression.
    Schachtner, T.
    Stein, M.
    Reinke, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 536 - 536
  • [43] MALIGNANCIES UNDER MTOR-INHIBITOR BASED IMMUNOSUPPRESSION AFTER SOLID ORGAN TRANSPLANTATION - A SYSTEMATIC REVIEW AND METAANALYSIS
    Wolf, S.
    Hoffmann, V.
    Werner, J.
    Guba, M.
    Andrassy, J.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 34 - 34
  • [44] Immunosuppression with a mTOR-Inhibitor Might Be Associated With a Lower CMV-DNA Incidence in Bile After Orthotopic Liver Transplantation
    Rauber, Conrad
    Drueckhammer, Marlena
    Friedrich, Kilian
    Rupp, Christian
    Wannhoff, Andreas
    Stremmel, Wolfgang
    Schemmer, Peter
    Weiss, Karl H.
    Schnitzler, Paul
    Gotthardt, Daniel N.
    [J]. TRANSPLANTATION, 2015, 99 : 151 - 151
  • [45] Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review
    Riera-Mestre, Antoni
    Cerda, Pau
    Carolina Guzman, Yoelimar
    Iriarte, Adriana
    Torroella, Alba
    Maria Mora-Lujan, Jose
    Castellote, Jose
    Hessheimer, Amelia
    Fondevila, Constantino
    Llado, Laura
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [46] Orthotopic liver transplantation and hereditary hemorrhagic telangiectasia:: do hepatic vascular malformations relapse?: A long term follow up study on two patients
    Sabbà, C
    Gallitelli, M
    Longo, A
    Cariati, M
    Angelelli, G
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (04) : 687 - 689
  • [47] Letter to the Editor: Toxin-induced graft injury following liver transplantation for yellow phosphorus poisoning
    Varghese, Joy
    Malleswaran, Selvakumar
    Mouleeswaran, Karattupaayam
    [J]. HEPATOLOGY, 2022, 75 (01) : 231 - 232
  • [48] CONVERSION TO A SIROLIMIS-BASED CALCINEURIN INHIBITOR (CNI) FREE IMMUNOSUPPRESSION FOR NEUROTOXICITY IN LIVER TRANSPLANTATION
    McKenna, Greg J.
    Sanchez, Edmund Q.
    Chinnakotla, Srinath
    Randall, Henry B.
    Ruiz, Richard
    Onaca, Nicholas
    Goldstein, Robert M.
    Levy, Marlon F.
    Klintmalm, Goran B.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S78 - S78
  • [49] Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
    Jan Steffen Jürgensen
    Robert Ikenberg
    Roger-Axel Greiner
    Volker Hösel
    [J]. The European Journal of Health Economics, 2015, 16 : 377 - 390
  • [50] Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
    Juergensen, Jan Steffen
    Ikenberg, Robert
    Greiner, Roger-Axel
    Hoesel, Volker
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (04): : 377 - 390
12345